Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients
Clinical trial NCT02994784 · TERMINATED
Trial details
- NCT number
- NCT02994784
- Sponsor
- Boston Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-08
- Primary completion
- 2022-07-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.